Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002327865 | SCV002630658 | pathogenic | Hereditary cancer-predisposing syndrome | 2019-01-03 | criteria provided, single submitter | clinical testing | The c.420_421insTT pathogenic mutation, located in coding exon 3 of the MSH2 gene, results from an insertion of two nucleotides at position 420, causing a translational frameshift with a predicted alternate stop codon (p.M141Lfs*34). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |